Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Multiple Myeloma"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Myeloma%22&type=Subject&filter%5B%5D=topic_facet%3A%22Multiple+Myeloma%22
/vufind/Search/Results?lookfor=%22Myeloma%22&type=Subject&filter%5B%5D=topic_facet%3A%22Multiple+Myeloma%22
Search /vufind/Search2/Results?lookfor=%22Myeloma%22&type=Subject&filter%5B%5D=topic_facet%3A%22Multiple+Myeloma%22
PubPharm (7.333)
1
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30) : A PHASE 1B, OPEN-LABEL STUDY OF ELRANATAMAB IN COMBINATION WITH IBERDOMIDE IN PARTICIPANTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) : A PHASE 3, OPEN-LABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMAB, POMALIDOMIDE, DEXAMETHASONE (EPd) OR POMALIDOMIDE, BORTEZOMIB, DEXAMETHASONE (PVd) OR CARFILZOMIB, DEXAMETHASONE (Kd) IN PARTICIPANTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WHO RECEIVED PRIOR ANTI-CD38 DIRECTED THERAPY
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
18F-Fluciclovine PET/CT in Multiple Myeloma : A Phase II Trial Evaluating 18F-Fluciclovine PET/CT in Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma : A PHASE 1B, OPEN-LABEL STUDY OF ELRANATAMAB IN COMBINATION WITH CARFILZOMIB PLUS DEXAMETHASONE AND ELRANATAMAB IN COMBINATION WITH PF-07901801 IN PARTICIPANTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant : A RANDOMIZED, 2-ARM, PHASE 3 STUDY OF ELRANATAMAB (PF-06863135) VERSUS LENALIDOMIDE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA AFTER UNDERGOING AUTOLOGOUS STEM-CELL TRANSPLANTATION
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders : Prospective Multi-Center Study to Identify Barriers to Cellular Therapies in Patients With Plasma Cell Disorders PROACT PCD
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory Multiple Myeloma : A Modular Phase I/II, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Lmmunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0305 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Relapsed or Refractory Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma : A Phase II Study of Sequential Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Newly Diagnosed Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Personalized Autologous Transplant for Multiple Myeloma : Phase 1 of Exposure Targeted Melphalan Dosing
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F) : MATCH Treatment Subprotocol F: Crizotinib in Patients With Tumors (Other Than Adenocarcinoma of Lung or ALCL) With ALK Rearrangements
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[734]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Multiple Myeloma
Medienart
7.286
Aufsätze
6.008
E-Ressourcen
5.985
E-Artikel
1.301
Gedruckte Aufsätze
47
Bücher
24
Gedruckte Bücher
23
E-Books
1
Hochschulschriften
Alle anzeigen ...
weniger ...
Zeitschriftentitel
3.086
ClinicalTrials.gov
1.401
Reactions weekly
800
Inpharma weekly
269
Annals of hematology
175
PharmacoEconomics & outcomes news
88
International journal of hematology
63
Drugs
49
Inpharma
43
BMC cancer
36
Current treatment options in oncology
30
Current hematologic malignancy reports
27
Journal of cancer research and clinical oncology
26
Journal of medical case reports
22
Cancer chemotherapy and pharmacology
21
Digestive diseases and sciences
20
Journal for ImmunoTherapy of Cancer
19
PharmacoEconomics
18
Drugs & aging
17
European journal of nuclear medicine and molecu...
17
Journal of hematology & oncology
Alle anzeigen ...
weniger ...
Thema
Multiple Myeloma
3.086
610
2.643
Study Type: Interventional
2.592
Neoplasms, Plasma Cell
1.334
Myeloma
1.195
Recruitment Status: Completed
943
Phase: Phase 2
812
Medical Condition: Multiple Myeloma
705
Bortezomib
689
Recruitment Status: Recruiting
639
Phase: Phase 1
587
Thalidomide
495
Dexamethasone
453
Lymphoma
406
Study Type: Observational
403
Recruitment Status: Active, not recruiting
370
Recruitment Status: Terminated
325
Zoledronic Acid
321
Leukemia
311
Lenalidomide
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2.063
2020-
2.510
2010-2019
1.545
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
7.309
Englisch
11
Chinesisch
9
Deutsch
3
Russisch
3
Spanisch
3
Ukrainisch
2
Persisch
2
Portugiesisch
1
Französisch
1
Polnisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...